Doi R et al. |
Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini. |
1993 |
J. Pharmacol. Exp. Ther. |
pmid:7679738
|
Cavaillé-Coll M and Mielach FA |
Choice of cyclophosphamide dose in baboon-to-human liver transplantation. |
1993 |
Lancet |
pmid:7679768
|
Kobayashi M et al. |
HLA-DR matching effect in orthotopic liver transplantation under FK 506. |
1993 |
Transplant. Proc. |
pmid:7679812
|
Watanabe K et al. |
Fate of long-surviving allografts in tolerant recipients induced by fractionated lymphoid irradiation, donor bone marrow cell infusion, and FK 506 after retransplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679813
|
Valdivia LA et al. |
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. |
1993 |
Transplant. Proc. |
pmid:7679816
|
Murase N et al. |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. |
1993 |
Transplant. Proc. |
pmid:7679817
|
Schreier MH et al. |
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? |
1993 |
Transplant. Proc. |
pmid:7679818
|
Kahan BD |
Cyclosporine: the base for immunosuppressive therapy--present and future. |
1993 |
Transplant. Proc. |
pmid:7679819
|
Starzl TE |
FK 506 versus cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679820
|
Nakajima K et al. |
Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679821
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. |
1993 |
Transplant. Proc. |
pmid:7679843
|
Inoue T et al. |
Isolation of mitochondrial cyclophilin from bovine heart. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7679902
|
Stephens J et al. |
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. |
1993 |
Transplant. Proc. |
pmid:7680144
|
Bonet H et al. |
Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. |
1993 |
Transplant. Proc. |
pmid:7680145
|
Fung J et al. |
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7680146
|
Shibata T et al. |
Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? |
1993 |
Transplant. Proc. |
pmid:7680147
|
Todo S et al. |
Intestinal transplantation in humans under FK 506. |
1993 |
Transplant. Proc. |
pmid:7680148
|
Reyes J et al. |
Nutritional management of intestinal transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7680149
|
Abu-Elmagd KM et al. |
Monitoring and treatment of intestinal allograft rejection in humans. |
1993 |
Transplant. Proc. |
pmid:7680150
|
McCauley J et al. |
FK 506 in the management of nephrotic syndrome after renal transplantation. |
1993 |
Transplant. Proc. |
pmid:7680154
|
Mañez R et al. |
Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7680170
|
McCauley J |
The nephrotoxicity of FK506 as compared with cyclosporine. |
1993 |
Curr. Opin. Nephrol. Hypertens. |
pmid:7532089
|
Rotonda J et al. |
Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis. |
1993 |
J. Biol. Chem. |
pmid:7681823
|
Xu RX et al. |
1H, 13C, and 15N assignments and secondary structure of the FK506 binding protein when bound to ascomycin. |
1993 |
Biopolymers |
pmid:7682113
|
Tanaka N et al. |
Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506. |
1993 |
Int. J. Immunopharmacol. |
pmid:7682200
|
Bruserud O and Pawelec G |
Cyclosporine A and FK506 show similar immunosuppressive effects on long-term in vitro T-cell proliferation. |
1993 |
Int. J. Immunopharmacol. |
pmid:7682202
|
Winkler M et al. |
Anaemia associated with FK 506 immunosuppression. |
1993 |
Lancet |
pmid:7682273
|
Lundemose AG et al. |
Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. |
1993 |
Mol. Microbiol. |
pmid:7682281
|
Wiesner RH et al. |
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. |
1993 |
Transplant. Proc. |
pmid:7682352
|
Frank B et al. |
Neurotoxicity of FK 506 in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7682355
|
Klintmalm GB et al. |
Rejection: FK 506 for rescue or maintenance. |
1993 |
Transplant. Proc. |
pmid:7682356
|
Woodle ES et al. |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. |
1993 |
Transplant. Proc. |
pmid:7682358
|
Thomson AW et al. |
ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. |
1993 |
Autoimmunity |
pmid:7505632
|
López-Gil JA and GarcÃa Sáiz M |
[FK506: an immunosuppressor for the '90's?]. |
1993 |
Med Clin (Barc) |
pmid:7505871
|
Kagayama A et al. |
Oral absorption of FK506 in rats. |
1993 |
Pharm. Res. |
pmid:7505939
|
Kim YI et al. |
Augmentation of hepatocyte proliferation by immunosuppressant pretherapy is associated with up-regulation of malondialdehyde production. |
1993 |
Res Exp Med (Berl) |
pmid:7506444
|
Hytiroglou P et al. |
FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations. |
1993 |
Transplantation |
pmid:7506452
|
Ishizuka J et al. |
Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. |
1993 |
Transplantation |
pmid:7506454
|
Dhar DK et al. |
Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment. |
1993 |
Transplantation |
pmid:7506456
|
Fabrega AJ et al. |
Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. |
1993 |
Transplantation |
pmid:7506458
|
Jain A et al. |
FK506 and pregnancy in liver transplant patients. |
1993 |
Transplantation |
pmid:7506459
|
Winkler ME et al. |
Successful pregnancy in a patient after liver transplantation maintained on FK 506. |
1993 |
Transplantation |
pmid:7506460
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Tabasco-Minguillan J et al. |
Insulin requirements after liver transplantation and FK-506 immunosuppression. |
1993 |
Transplantation |
pmid:7692637
|
Wang SC et al. |
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. |
1993 |
Transplantation |
pmid:7692640
|
Akita K and Mandel TE |
Effect of FK 506 and anti-CD4 monoclonal antibody treatment on xenografts of organ-cultured fetal pig pancreas and host lymphoid populations. |
1993 |
Transplant. Proc. |
pmid:7692650
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
David M et al. |
[Changes in cervix cytology in women with liver transplants treated with immunosuppressive therapy]. |
1993 |
Zentralbl Gynakol |
pmid:7692689
|
Wallemacq PE and Reding R |
FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. |
1993 |
Clin. Chem. |
pmid:7693372
|
Nakamura T et al. |
Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. |
1993 |
EMBO J. |
pmid:7693452
|
Higa A et al. |
Attenuation of epithelial injury in acute experimental colitis by immunomodulators. |
1993 |
Eur. J. Pharmacol. |
pmid:7693488
|
Schmitt J et al. |
Cloning and expression of a mouse cDNA encoding p59, an immunophilin that associates with the glucocorticoid receptor. |
1993 |
Gene |
pmid:7693550
|
Iwasaki K et al. |
Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes. |
1993 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:7508138
|
Takada K et al. |
Distribution characteristics of immunosuppressants FK506 and cyclosporin A in the blood compartment. |
1993 |
Biopharm Drug Dispos |
pmid:7508273
|
Sperr WR et al. |
[Effector cells in allergy: biological principles and new pharmacologic concepts]. |
1993 |
Wien. Klin. Wochenschr. |
pmid:7508662
|
Ohtake M et al. |
Enhanced liver regeneration in rats treated with 15-deoxyspergualin alone and in combination with FK 506. |
1993 |
Gastroenterol. Jpn. |
pmid:7683616
|
Ohnishi H et al. |
Natural killer cell may impair liver regeneration in fulminant hepatic failure. |
1993 |
Gastroenterol. Jpn. |
pmid:7683619
|
Natazuka T et al. |
FK506 and cyclosporin a regulate proliferation and proto-oncogene expression in HTLV-1-associated myelopathy/tropical-spastic-paraparesis-derived T cells. |
1993 |
Int. J. Cancer |
pmid:7683633
|
Mukai H et al. |
FKBP12-FK506 complex inhibits phosphatase activity of two mammalian isoforms of calcineurin irrespective of their substrates or activation mechanisms. |
1993 |
J. Biochem. |
pmid:7683641
|
Jachez B et al. |
Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives. |
1993 |
Anticancer Drugs |
pmid:7683935
|
Shapiro R et al. |
FK 506 interaction with danazol. |
1993 |
Lancet |
pmid:7684106
|
Becker JW et al. |
FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. |
1993 |
J. Biol. Chem. |
pmid:7684380
|
Dickey JB et al. |
Periocular FK-506 delays allograft rejection in rat penetrating keratoplasty. |
1993 |
Cornea |
pmid:7684663
|
McMichael J et al. |
Computer-guided concentration-controlled trials in autoimmune disorders. |
1993 |
Ther Drug Monit |
pmid:7510078
|
Francavilla A et al. |
Hepatic regeneration and growth factors. |
1993 |
J Surg Oncol Suppl |
pmid:7684910
|
Lemster B et al. |
Blood lymphocytes of autoimmune disease patients receiving FK506 exhibit normal ex vivo cytokine gene expression and proliferative responses. |
1993 |
Immunol. Lett. |
pmid:7510265
|
Connelly PR et al. |
Probing hydration contributions to the thermodynamics of ligand binding by proteins. Enthalpy and heat capacity changes of tacrolimus and rapamycin binding to FK506 binding protein in D2O and H2O. |
1993 |
Biochemistry |
pmid:7684925
|
Parent SA et al. |
Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae. |
1993 |
J. Gen. Microbiol. |
pmid:7510323
|
Sakr MF et al. |
FK 506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion. |
1993 |
J. Hepatol. |
pmid:7686193
|
Calne RY et al. |
Intestinal transplant for recurring mesenteric desmoid tumour. |
1993 |
Lancet |
pmid:7686241
|
Langer A et al. |
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. |
1993 |
Am. J. Pathol. |
pmid:7686346
|
Henke W and Jung K |
Comparison of the effects of the immunosuppressive agents FK 506 and cyclosporin A on rat kidney mitochondria. |
1993 |
Biochem. Pharmacol. |
pmid:7690566
|
Fujisawa T et al. |
Dose study of the immunosuppression of FK 506 in canine lung allo-transplantation. |
1993 |
Surg. Today |
pmid:7686416
|
Ueno M et al. |
[Immunosuppressive effect in combination therapy of cyclosporine A, FK506 and 15-deoxyspergualin on a pancreatic islet xenotransplantation]. |
1993 |
Nihon Geka Gakkai Zasshi |
pmid:7686615
|
Murase N et al. |
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. |
1993 |
Transplantation |
pmid:7682735
|
Thomson AW et al. |
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. |
1993 |
Springer Semin. Immunopathol. |
pmid:7686690
|
Emond JC et al. |
Improved results of living-related liver transplantation with routine application in a pediatric program. |
1993 |
Transplantation |
pmid:7682738
|
Kai N et al. |
Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. |
1993 |
Transplantation |
pmid:7682740
|
Koga T et al. |
Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease. |
1993 |
Chest |
pmid:7686837
|
Nishi M et al. |
Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. |
1993 |
Invest. Ophthalmol. Vis. Sci. |
pmid:7686893
|
Nishizawa S et al. |
Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. |
1993 |
Neurosurgery |
pmid:7687044
|
Abu-Elmagd K et al. |
Recent advances in hepatic transplantation at the University of Pittsburgh. |
1993 |
Clin Transpl |
pmid:7522528
|
Hoof T et al. |
Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin. |
1993 |
Eur. J. Pharmacol. |
pmid:7689059
|
Jin YJ and Burakoff SJ |
The 25-kDa FK506-binding protein is localized in the nucleus and associates with casein kinase II and nucleolin. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7689229
|
Taylor-Fishwick DA et al. |
Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use. |
1993 |
Transplantation |
pmid:7689258
|
Shaefer MS et al. |
Falsely elevated FK-506 levels caused by sampling through central venous catheters. |
1993 |
Transplantation |
pmid:7689264
|
Valdivia LA et al. |
Dendritic cell replacement in long-surviving liver and cardiac xenografts. |
1993 |
Transplantation |
pmid:7689265
|
Odocha O et al. |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689268
|
Odocha O et al. |
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689269
|
McCauley J et al. |
Renal transplantation under FK 506 in African-Americans: early experience. |
1993 |
Transplant. Proc. |
pmid:7689270
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
McMaster P and Buist L |
FK 506 in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689275
|
Jost U et al. |
FK 506 treatment of intractable rejection after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689276
|
Jain AB et al. |
Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. |
1993 |
J Clin Pharmacol |
pmid:7690047
|
Cheng JW et al. |
15N NMR relaxation studies of the FK506 binding protein: backbone dynamics of the uncomplexed receptor. |
1993 |
Biochemistry |
pmid:7690248
|
Cetinkale O et al. |
The use of FK506 and skin allografting for the treatment of severe burns in an animal model. |
1993 |
Br J Plast Surg |
pmid:7690295
|
Hom JT and Estridge T |
FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils. |
1993 |
Clin. Immunol. Immunopathol. |
pmid:7690315
|
Olivera DL et al. |
Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation. |
1993 |
Clin. Immunol. Immunopathol. |
pmid:7690317
|
Whitington PF et al. |
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. |
1993 |
Lancet |
pmid:7690444
|
Hirasé Y et al. |
Transplantation of long-term cryopreserved allocutaneous tissue by skin graft or microsurgical anastomosis: experimental studies in the rat. |
1993 |
Plast. Reconstr. Surg. |
pmid:7679796
|